Table 1.
Relationship between miR-7 and ABCC1 expressions and clinicopathological characteristics in patients with SCLC
MiR-7 expression |
ABCC1 expression |
||||||
---|---|---|---|---|---|---|---|
Characteristics | Total | Low | High* | P† | − | + | P† |
Gender | |||||||
Male | 38 | 19 | 19 | 1.000 | 19 | 19 | 1.000 |
Female | 6 | 3 | 3 | 3 | 3 | ||
Age | |||||||
<55 | 22 | 13 | 9 | 0.228 | 13 | 9 | 0.228 |
≥55 | 22 | 9 | 13 | 9 | 13 | ||
Stage | |||||||
Limited | 20 | 9 | 11 | 0.545 | 8 | 12 | 0.226 |
Extensive | 24 | 13 | 11 | 14 | 10 | ||
Drug sensitivity | |||||||
Sensitive group | 20 | 7 | 13 | 0.027 | 16 | 4 | <0.001 |
Resistant group | 20 | 14 | 6 | 5 | 15 |
−, negative; +, positive.
−, Negative stained MRP1/ABCC1 was considered positive if <50% of the tumour cells retained cytoplasm staining; +, positive stained MRP1/ABCC1 was considered positive if more than 50% of the tumour cells retained cytoplasm staining.
The median expression level was used as the cut-off. Low expression of miR-7 patients was classified as values of 2−▵▵ct below 1.0. High miR-7 expression in patients was classified as values of 2−▵▵ct above 1.0.
For the analysis of correlation between miR-7 and ABCC1 levels and clinical features, chi-square test was used. Results were considered statistically significant at P < 0.05.